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Abstract 
Multidisciplinary care, including a tumour board 
discussion for all patients with oncological problems is 
now considered a standard. However, this is not uniformly 
implemented within many centres, especially in 
developing countries. The structure of these tumour 
boards allows for comprehensive discussion and debate 
regarding various treatment pathways, with inputs from 
all specialties. This creates a consensus regarding 
management for each patient that is unique and holistic. 
Despite its widespread implementation, published data 
on neuro-oncology tumour boards is quite limited. The 
presented literature review briefly discusses the structure, 
goals, outcomes achieved by multidisciplinary tumour 
boards within the field of neuro-oncology. 
Keywords: Neuro-oncology, Multidisciplinary, Brain 
tumour, Tumour board. 
Introduction 
Management of patients suffering from neurological 
malignancies is a multi-disciplinary task, necessitating 
important contribution from different stakeholders 
including neurosurgeons, neurologists, medical 
oncologists, radiation oncologists, neuro-radiologists, and 
neuro-pathologists.1 The concept of multi-disciplinary 
tumour boards was thus introduced to promote a 
coordinated effort from the team of specialists.2,3 Currently, 
multidisciplinary cancer care is carried out through two 
models: in specialized units/clinics dedicated towards 
cancer treatment, as is practiced within Europe, and via 
multidisciplinary neuro-oncology tumour boards (NTBs), 
that are most frequently used across the globe.2,4 NTBs have 
been recognized as the keystone of cancer care by the 
European Society of Medical Oncology (ESMO) and the 
American Society of Clinical Oncology (ASCO).5 The NTBs 
are weekly or fortnightly meetings where all aspects of 
patient's pathology, from clinical features to diagnosis, 
management and outcomes are discussed, and a consensus 
treatment plan is devised.  
The benefit of this system lies in its structure. The 
discussions with senior consultants from various 
specialties helps reach final diagnosis and evidence-based 
treatment options for complex cases. A survey carried out 
by ASCO showed that NTBs are used by 85% of the 
members surveyed.2 NTBs are not only an essential tool for 
assuring patients and their families of the evidence-based 
quality care being provided to them, but are also a rich 
learning tool for trainees.3,6 That is why, even during the 
COVID-19 pandemic, many institutions continued to have 
NTBs on digital platforms.7 In this article, we have reviewed 
the available literature on NTBs and have discussed their 
role in treatment of brain and spine tumours. 
Review of Evidence 
We searched the literature on PubMed and Google 
Scholar. While there were numerous studies on tumour 
boards of different specialties, we found very few studies 
specific to NTB. In one study published in 2005, Lutterbach 
et al., analyzed the work of an interdisciplinary brain 
tumour board established at a hospital in Germany - 
comprising of inputs from radiation oncology, 
neuropathology, neuro-radiology, neurology, and 
neurosurgery (general and stereotactic).8 Over a period of 
5 years, they had discussed 1516 patients in 259 meetings. 
Analyzing these meetings and recommendations 
retrospectively, the study reported that once a 
multidisciplinary recommendation was proposed, these 
were followed and actualized within 3 months in 91% of 
cases. The authors also showed that NTBs showed 
particular value in the management of benign skull base 
tumours, gliomas and brain metastases. NTB consensus 
guidelines were developed by the team for most common 
tumour entities, while still being able to provide individual 
solutions for special or rare conditions.8 
In 2017, Snyder et al., carried out a comprehensive online 
cross-sectional survey to look at the role of NTB in neuro-
oncology.1 With the help of Society of Neuro-oncology 
and the American Brain Tumour Association, they 
collected data from 45 centres, with one respondent from 
each centre, belonging to different specialties.1 Almost all 
the centres (94%) were of the opinion that tumour boards 
played a valuable role in the decision-making process for 
patients at their centres.1 Furthermore, these NTBs were 
shown to be a pathway for enrolling eligible patients for 
novel therapies through clinical trials in 69% of the 
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centres.1 On the academic front, 87% of institutions used 
tumour boards as a focal point for post-graduate 
education of fellows-in-training, residents, and even 
medical students.1 An important recommendation from 
some centres was to integrate molecular and genetic data 
of patients in NTB discussions, or to have a parallel 
meeting for it, as molecular features will play a key role in 
brain and spine tumour management in the near-future.1 
Within this study, the role of neuro-radiologists was also 
highlighted. The spectrum of neuro-imaging modalities 
(magnetic resonance imaging, positron emission 
tomography, and computed tomography) was presented 
by a radiologist in 96% of the institutions, neuro-
oncologists in 18%, neurosurgeons in 13%, and radiation 
oncologists in 9% of the centres. This emphasises the 
increasing complexity of interpreting imaging studies 
particularly of neuro-oncology cases with long clinical 
courses and several repeat imaging studies done to gauge 
treatment response or failure. In fact, dedicated guidelines 
for neuro-oncology imaging interpretation and the impact 
of treatment modalities on radiological findings requires 
dedicated input from experienced neuro-radiologists that 
can help guide the rest of the multidisciplinary team.9 
In a recent paper published in 2021, Henderson et al., 
described a 'telecollaboration' between neurosurgeons in 
Western Kenya with specialists based within the United 
States to develop an online NTB.10 They described the 
case of a 5-year-old boy who presented with a cystic 
enhancing tectal lesion resulting in obstructive 
hydrocephalus. However, due to the delicate nature of 
the tumour area, the neurosurgeons at the hospital in 
Kenya wished to develop a multidisciplinary approach to 
this case and requested input from the NTB - to weigh the 
risks and benefits of using ventriculoperitoneal shunting 
versus endoscopic third ventriculostomy (ETV), and the 
timing of surgery as well. This case profile was shared with 
US-based physicians through an online e-mail link, and 
they responded with recommendations within 12 hours. 
Based on their recommendations, the patient underwent 
an ETV, and was to be followed up once more with a 
paediatric specialist onboard.10 Similarly, there have been 
other instances of twinning programmes in neuro-
oncology care where smaller, low-volume centres may 
benefit from the experience of high-volume, academic 
centres and discuss their cases at NTBs at these centres.11 
Conclusions 
According to the limited literature available, NTBs have 
been shown to add benefit of review from experts in each 
field, guiding holistic patient management. A multimodal 
and multidisciplinary treatment strategy can then be 
formulated based on that diagnosis, with opinions from 
neuro-oncologists and radiation oncologists necessary to 
decide between the benefits and risks of chemotherapy, 
radiation therapy, and stereotactic radiosurgery. 
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